The COVID-19 Clinical Research Coalition is working with the ACT-Accelerator Therapeutics Partnership to increase the representation of researchers from low- and middle-income countries in the Therapeutics Partnership’s workstreams. We are seeking researchers with relevant research expertise, technical competence, a commitment to the principles of equitable access for all, and a desire to represent the research priorities of low-resource settings in these workstreams.

Following a successful webinar on Ethics review mutual recognition, the Ethics Working Group of the COVID-19 Clinical Research Coalition is sharing the findings of a project, funded by the World Health Organization, aiming to review the challenges and opportunities of ethics review mutual recognition for COVID-19 multi-site research protocols.

Médecins Sans Frontières and the Drugs for Neglected Diseases initiative hosted a webinar to discuss the implications of the TRIPs waiver proposal for Africa, and why countries should support it.

Prof. Francine Ntoumi was recently appointed member of the Scientific Advisory Board of the French Institute for Research Development (IRD).

Dr Luisa Enria has been awarded the annual Sanjaya Lall Prize for the best article published in the journal Oxford Development Studies in the preceding year's issue.

The COVID-19 Clinical Research Coalition and PHEPREN (Public Health Emergency and Response Ethics Network) hosted a webinar to share the findings of a project undertaken in collaboration with the Ethics Working Group to review the challenges and opportunities of ethics review mutual recognition for COVID-19 multi-site research protocols.

ORAS-CONHU hosted a webinar about the COVID-19 Clinical Research Coalition with speakers from the coalition’s Steering Committee and several expert working groups. Available in English and Spanish.

In this webinar, scientists from Brazil, India, Thailand, and the US discuss the ethics, safety, and justification for evaluating hydroxychloroquine and chloroquine to prevent COVID-19, in a context of guidance having been recently issued by the World Health Organization to halt the use of these drugs to treat the disease.

The Social Science Working Group organized a webinar on social science research and community engagement in vaccine clinical trials in low-resource settings. This is the first of a three-webinar series on the social science of vaccine development and deployment.

In response to a Lancet Digital Health Editorial regarding transparency during global health emergencies, the Data Sharing Working Group published a letter outlining the rationale and aims of the group.